Intro

This chapter explores Teva Pharmaceuticals' recent performance and their decision to uphold revenue guidance despite falling short of sales estimates. It also discusses the potential impact of new U.S.-EU tariffs on the pharmaceutical industry and Teva's operational strategies moving forward.